Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • EELS (Ethical Economic Legal and Social) Article
  • Published:

EELS (Ethical, Economic, Legal & Social) Article

Pharmacogenomics and the (ir)relevance of race

The Pharmacogenomics Journal volume 1, pages 104–108 (2001)Cite this article

Race,Footnote 1 as opposed to ethnicity, is a predictor of questionable value for differences in susceptibility to, and pathogenesis of, disease susceptibility. As social constructs, however, both race and ethnicity are powerful organizing forces employed both by those who use differences to stigmatize and those who view differences as a source of pride, community, and shared history. Even as society acknowledges that humans are more alike than different, efforts to eliminate race in medical research are met with as much suspicion as those attempts to employ race in research design. In some instances, the opposition to abandon racial categories has come from those groups who have historically suffered poor treatment or stigma based on race. History has bred distrust among historically disfavored population groups of the possible agendas of those who would now abandon racial categories as a marker or measuring stick for any purpose.

For purposes of this discussion, the term ‘race’ is defined as ‘a distinct ethnic group characterized by traits that are transmitted through their offspring’. An ethnic group is ‘a social group or category of the population that, in a larger society, is set apart and bound together by common ties of race, language, nationality or culture’. Census, Race and Science. Nat Genet 2000; 24: 97–98.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Notes

  1. For purposes of this discussion, the term ‘race’ is defined as ‘a distinct ethnic group characterized by traits that are transmitted through their offspring’. An ethnic group is ‘a social group or category of the population that, in a larger society, is set apart and bound together by common ties of race, language, nationality or culture’. Census, Race and Science. Nat Genet 2000; 24: 97–98.

  2. ‡Ultimately, the aim of pharmacogenomics is to enable physicians to tailor drug therapy to the individual based on that individual’s genotype.

References

  1. Reference deleted in proof

  2. RS Schwartz . Racial profiling in medical research N Eng J Med 2001 344: 1392–1393

    Article  CAS  Google Scholar 

  3. J Gu et al. Ethnic differences in poly CADP-ribose polymerase pseudogene genotype distribution association with lung cancer risk Carcinogenesis 1999 20: 1465–1469

    Article  CAS  Google Scholar 

  4. CM Stein et al . Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race Pharmacogenetics 2001 11: 95–110

    Article  CAS  Google Scholar 

  5. S Olson . Genetic archaeology of race Atl Monthly 2001 287: 69–80

    Google Scholar 

  6. Reference deleted in proof

  7. MM Shi et al. Pharmacogenetic application in drug development and clinical trials Drug Metab Dispos 2001 29: 591–595

    CAS  PubMed  Google Scholar 

  8. J Hanke . Genomics and new technologies as catalysts for change in the drug discovery paradigm Whitehead Policy Symposium 2000

    Google Scholar 

  9. WW Weber . Pharmacogenetics Oxford University Press: New York 1997

    Google Scholar 

  10. EJ Carlini et al. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects Pharmacogenetics 2001 11: 57–68

    Article  CAS  Google Scholar 

  11. HG Xie et al. Molecular basis of ethnic differences in drug disposition and response Annu Rev Pharmacol Toxicol 2001 41: 815–850

    Article  CAS  Google Scholar 

  12. HL McLeod, WE Evans . Pharmacogenomics: unlocking the human genome for better drug therapy Annu Rev Pharmacol Toxicol 2001 41: 101–121

    Article  CAS  Google Scholar 

  13. MM Ameyaw et al . MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity Pharmacogenetics 2001 11: 217–221

    Article  CAS  Google Scholar 

  14. International Human Genome Sequencing Consortium . Initial sequencing and analysis of the human genome Nature 2001 409: 860–921

    Article  Google Scholar 

  15. JC Venter et al . The sequence of the human genome Science 2001 291: 1304–1351

    Article  CAS  Google Scholar 

  16. GenBank (http://www.ncbi.nlm.nih.gov/GenBank)

  17. MD Shriver et al. Ethnic-affiliation estimation by use of populations—specific DNA markers Am J Hum Gen 1997 60: 957–964

    CAS  Google Scholar 

  18. CM Stein et al . Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race Pharmacogenetics 2001 11: 95–110

    Article  CAS  Google Scholar 

  19. MA Rothstein, PG Epps . Ethical and legal implications of pharmacogenomics Nat Rev Gen 2001 2: 228–231

    Article  CAS  Google Scholar 

  20. National Institutes of Health Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research 59 Fed Reg 14508, Mar 28 1994

  21. Centers for Disease Control Policy on the Inclusion of Women and Racial and Ethnic Minorities in Externally Awarded Research 60 Fed Reg 47947, Sep 15 1995

  22. M Foster, R Sharp, J Mulvihill . Pharmacogenetics, race and ethnicity: social identities and individualized medical care Therapeut Drug Monit 2001 23: 232–238

    Article  CAS  Google Scholar 

  23. AM Epstein, JZ Ayanian . Racial disparities in medical care New Eng J Med 2001 344: 1471–1473

    Article  CAS  Google Scholar 

  24. United States Department of Health & Human Services The Initiative to Eliminate Racial and Ethnic Disparities in Health (http://raceandhealth.hhs.gov)

  25. J Gu et al . Ethnic differences in poly CADP-ribose polymerase pseudogene genotype distribution association with lung cancer risk Carcinogenesis 1999 20: 1465–1469

    Article  CAS  Google Scholar 

  26. J Chen et al . Racial differences in the use of cardiac catherization after acute myocardial infarction New Eng J Med 2001 344: 1443–1449

    Article  CAS  Google Scholar 

  27. S Satel . The indoctrinologists are coming Atl Monthly 2001 287: 59–64

    Google Scholar 

  28. AJJ Wood . Racial differences in the response to drugs—pointers to genetic differences New Eng J Med 2001 344: 1393–1396

    Article  Google Scholar 

  29. Transcript, Interview with Dr Anne Taylor, CBS News: The Early Show, Mar 19, 2001

Download references

Author information

Authors and Affiliations

  1. University of Louisville School of Medicine, Louisville, KY, USA

    M A Rothstein

  2. University of Houston Law Center, Houston, TX, USA

    P G Epps

Authors
  1. M A Rothstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P G Epps
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M A Rothstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothstein, M., Epps, P. Pharmacogenomics and the (ir)relevance of race. Pharmacogenomics J 1, 104–108 (2001). https://doi.org/10.1038/sj.tpj.6500029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500029

This article is cited by

Search

Advanced search

Quick links